Slimming Products - Austria
Due to the introduction of Alli, consumers who are likely to use slimming products with the expectation of assisting in or replacing any weight-loss efforts, turned to the more ‘serious’ OTC obesity medication Alli, which was introduced in April 2009. That is why slimming products turnover declined by a sharp 11% to EUR13 million. Also, consumers are increasingly becoming educated about slimming products and do not get tempted by promises of miracle weight loss.
Euromonitor International's Slimming Products Products in Austria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage:Meal Replacement Slimming, Other Slimming Products, Slimming Teas, Weight Loss Supplements
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Euromonitor International's Slimming Products Products in Austria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage:Meal Replacement Slimming, Other Slimming Products, Slimming Teas, Weight Loss Supplements
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Consumer Health industry;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Executive Summary
Vat on Non-prescription Medicines Reduced From 20% To 10%
Health Increasingly Associated With Lifestyle
Bayer the Clear Leader in Consumer Health
Parapharmacies/drugstores Stronger
Future Impact of Tax Reduction Overestimated
Key Trends and Developments
Special Kind of Polarisation
Best Agers Driving Growth Sectors
Lifestyle Changes Impact Demand for OTC Products
Emotional Problems Affect Calming and Digestion
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC Healthcare Switches 2007-2009
Definitions
Sector and Subsector Definitions
Summary 2 Research Sources
Apomedica GmbH & Co Kg
Strategic Direction
Key Facts
Summary 3 Apomedica GmbH & Co KG: Key Facts
Summary 4 Apomedica GmbH & Co KG: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Apomedica GmbH & Co KG: Competitive Position 2009
Genericon Pharma Gesmbh
Strategic Direction
Key Facts
Summary 6 Genericon Pharma GesmbH: Key Facts
Summary 7 Genericon Pharma GesmbH: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 8 Genericon Pharma GesmbH: Competitive Position 2009
Kwizda F Joh GmbH
Strategic Direction
Key Facts
Summary 9 Kwizda F Joh GmbH: Key Facts
Summary 10 Kwizda F Joh GmbH: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 11 Kwizda F Joh GmbH: Competitive Position 2009
Sanova Pharma Gesmbh
Strategic Direction
Key Facts
Summary 12 Sanova Pharma Gesmbh: Key Facts
Company Background
Production
Competitive Positioning
Summary 13 Sanova Pharma Gesmbh: Competitive Position 2009
Wellness Co Gesmbh, the
Strategic Direction
Key Facts
Summary 14 Wellness Co GesmbH, The: Key Facts
Company Background
Production
Competitive Positioning
Summary 15 Wellness Co GesmbH, The: Competitive Position 2009
Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 12 Sales of Slimming Products by Subsector: Value 2004-2009
Table 13 Sales of Slimming Products by Subsector: % Value Growth 2004-2009
Table 14 Slimming Products Company Shares 2005-2009
Table 15 Slimming Products Brand Shares 2006-2009
Table 16 Forecast Sales of Slimming Products by Subsector: Value 2009-2014
Table 17 Forecast Sales of Slimming Products by Subsector: % Value Growth 2009-2014
Vat on Non-prescription Medicines Reduced From 20% To 10%
Health Increasingly Associated With Lifestyle
Bayer the Clear Leader in Consumer Health
Parapharmacies/drugstores Stronger
Future Impact of Tax Reduction Overestimated
Key Trends and Developments
Special Kind of Polarisation
Best Agers Driving Growth Sectors
Lifestyle Changes Impact Demand for OTC Products
Emotional Problems Affect Calming and Digestion
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC Healthcare Switches 2007-2009
Definitions
Sector and Subsector Definitions
Summary 2 Research Sources
Apomedica GmbH & Co Kg
Strategic Direction
Key Facts
Summary 3 Apomedica GmbH & Co KG: Key Facts
Summary 4 Apomedica GmbH & Co KG: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 5 Apomedica GmbH & Co KG: Competitive Position 2009
Genericon Pharma Gesmbh
Strategic Direction
Key Facts
Summary 6 Genericon Pharma GesmbH: Key Facts
Summary 7 Genericon Pharma GesmbH: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 8 Genericon Pharma GesmbH: Competitive Position 2009
Kwizda F Joh GmbH
Strategic Direction
Key Facts
Summary 9 Kwizda F Joh GmbH: Key Facts
Summary 10 Kwizda F Joh GmbH: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 11 Kwizda F Joh GmbH: Competitive Position 2009
Sanova Pharma Gesmbh
Strategic Direction
Key Facts
Summary 12 Sanova Pharma Gesmbh: Key Facts
Company Background
Production
Competitive Positioning
Summary 13 Sanova Pharma Gesmbh: Competitive Position 2009
Wellness Co Gesmbh, the
Strategic Direction
Key Facts
Summary 14 Wellness Co GesmbH, The: Key Facts
Company Background
Production
Competitive Positioning
Summary 15 Wellness Co GesmbH, The: Competitive Position 2009
Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 12 Sales of Slimming Products by Subsector: Value 2004-2009
Table 13 Sales of Slimming Products by Subsector: % Value Growth 2004-2009
Table 14 Slimming Products Company Shares 2005-2009
Table 15 Slimming Products Brand Shares 2006-2009
Table 16 Forecast Sales of Slimming Products by Subsector: Value 2009-2014
Table 17 Forecast Sales of Slimming Products by Subsector: % Value Growth 2009-2014
